For people with undiagnosed kidney masses...

Find Confidence in Your Path Forward

Early, noninvasive clear cell renal cell carcinoma detection could help you plan next steps

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. A new, noninvasive way to identify this cancer could make earlier diagnosis possible for more people. It could also help you and your doctors make informed choices about your treatment.

LEARN ABOUT NEW IMAGING

For people with undiagnosed kidney masses...

Find Confidence in Your Path Forward

Early, noninvasive clear cell renal cell carcinoma detection could help you plan next steps

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. A new, noninvasive way to identify this cancer could make earlier diagnosis possible for more people. It could also help you and your doctors make informed choices about your treatment.

LEARN ABOUT NEW IMAGING

When ccRCC is found early, outcomes can improve.

No matter where you are on your care path, Telix Pharmaceuticals is committed to helping people with kidney cancer by researching new ways to identify and treat ccRCC.

Find Confidence in Your Path Forward

Early, noninvasive clear cell renal cell carcinoma detection could help you plan next steps

Find Confidence in Your Path Forward

Early, noninvasive clear cell renal cell carcinoma detection could help you plan next steps

When ccRCC is found early, outcomes can improve.

Kidney masses are not always easy to diagnose

Knowing what kind of kidney mass you have may offer you more treatment choices

Find support along your journey

No matter where you are on your care path, Telix Pharmaceuticals is committed to helping people with kidney cancer by researching new ways to identify and treat ccRCC.